These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38941508)

  • 1. Development of a Stability-Indicating Purity Method for Ubrogepant through Stress Degradation Analysis, Extraction, and Characterization of Unidentified Degradation Products Using Flash Chromatography, NMR, IR, and LC-MS.
    Reddy Vanga N; Ratnam K V; Ummiti K; Nadh Ratnakaram V
    J AOAC Int; 2024 Jun; ():. PubMed ID: 38941508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LC-HRMS and NMR studies for the characterization of degradation impurities of ubrogepant along with the in silico approaches for the prediction of degradation and toxicity.
    Chaganti S; Chauhan U; Bhatt N; Kommalapati H; Golla VM; Pilli P; Samanthula G
    J Pharm Biomed Anal; 2024 Jun; 243():116117. PubMed ID: 38522383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
    Lalitha Devi M; Chandrasekhar KB
    J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of validated stability indicating purity method based on the stress degradation behavior of gonadotropin-releasing hormone antagonist (ganirelix) in an injectable formulation using HPLC and LC-MS-QTOF.
    Ummiti K; Shanmukha Kumar JV
    Eur J Mass Spectrom (Chichester); 2021 Apr; 27(2-4):126-140. PubMed ID: 33823624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
    Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
    Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LC-MS-Compatible Chromatographic Method for Quantification of Potential Organic Impurities of Elagolix Sodium in Tablet Dosage Form with Identification of Major Degradation Products.
    Desai P; Prajapati R; Chokshi A
    J AOAC Int; 2023 May; 106(3):568-579. PubMed ID: 36721330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the hyphenated LC-MS/MS technique and NMR/IR spectroscopy for the identification of exemestane stress degradation products during the drug development.
    Stolarczyk EU; Rosa A; Kubiszewski M; Zagrodzka J; Cybulski M; Kaczmarek Ł
    Eur J Pharm Sci; 2017 Nov; 109():389-401. PubMed ID: 28865686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability-indicating HPLC method development and structural elucidation of novel degradation products in posaconazole injection by LC-TOF/MS, LC-MS/MS and NMR.
    Yang Y; Zhu X; Zhang F; Li W; Wu Y; Ding L
    J Pharm Biomed Anal; 2016 Jun; 125():165-77. PubMed ID: 27023129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A validated specific stability-indicating RP-HPLC assay method for Ambrisentan and its related substances.
    Narayana MB; Chandrasekhar KB; Rao BM
    J Chromatogr Sci; 2014 Sep; 52(8):818-25. PubMed ID: 23926121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of Two Robust Stability-Indicating Chromatographic Methods for Determination of Metolazone in Drug Substance and Pharmaceutical Dosage Form in the Presence of Its Degradation Products and Characterization of Main Degradation Products Based on LC-MS.
    Zaazaa HE; Abdel-Ghany R; Abdelkawy M; Sayed M
    J Chromatogr Sci; 2020 Apr; 58(3):251-261. PubMed ID: 31879759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective separation, detection of zotepine and mass spectral characterization of degradants by LC-MS/MS/QTOF.
    Talluri MVNK; Kandimalla NR; Bandu R; Chundi D; Marupaka R; Srinivas R
    J Pharm Anal; 2014 Apr; 4(2):107-116. PubMed ID: 29403872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities.
    Srinivasu P; Subbarao DV; Vegesna RV; Sudhakar Babu K
    J Pharm Biomed Anal; 2010 May; 52(1):142-8. PubMed ID: 20053517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and Characterization of an Oxidative Degradation Product of Fexofenadine, Development and Validation of a Stability-Indicating RP-UPLC Method for the Estimation of Process Related Impurities and Degradation Products of Fexofenadine in Pharmaceutical Formulations.
    Vaghela B; Rao SS; Reddy AM; Venkatesh P; Kumar N
    Sci Pharm; 2012; 80(2):295-309. PubMed ID: 22896817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impurity Profile of Bronchodilators used in Asthma: A Critical Review.
    Prajapati KJ; Kothari CS
    Curr Drug Discov Technol; 2018; 15(4):272-304. PubMed ID: 28875855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Method validation and characterization of stress degradation products of azelastine hydrochloride using LC-UV/PDA and LC-Q/TOF-MS studies.
    Shekhar S; Bali A
    Rapid Commun Mass Spectrom; 2024 Apr; 38(7):e9712. PubMed ID: 38351666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification, isolation, structural characterisation, synthesis and
    Bhamare P; Umadoss P; Upmanyu N; Dubey R
    Anal Methods; 2020 Apr; 12(14):1868-1881. PubMed ID: 39039727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LC-MS-MS Characterization of Forced Degradation Products of Fidarestat, a Novel Aldose Reductase Inhibitor: Development and Validation of a Stability-Indicating RP-HPLC Method.
    Talluri MV; Khatoon L; Kalariya PD; Chavan BB; Ragampeta S
    J Chromatogr Sci; 2015 Oct; 53(9):1588-96. PubMed ID: 26014964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Degradation Products and a Stability-Indicating RP-HPLC Method for the Determination of Flupirtine Maleate in Pharmaceutical Dosage Forms.
    Peraman R; Lalitha KV; Raja NM; Routhu HB
    Sci Pharm; 2014; 82(2):281-93. PubMed ID: 24959399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential degradation products of abemaciclib: Identification and structural characterization employing LC-Q/TOF-MS and NMR including mechanistic explanation.
    Kathar N; Rajput N; Jadav T; Sengupta P
    J Pharm Biomed Anal; 2024 Jan; 237():115762. PubMed ID: 37844364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.